VAERS reports by lot

GSK Hepatitis A lot 95DB2: VAERS reports

26 VAERS reports list lot 95DB2 as a GSK Hepatitis A vaccine, received between 2022-11-14 and 2024-08-26. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
26
Reports
4%
Marked serious
1
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological622%
Cardiac / Cardiovascular519%
Gastrointestinal519%
Respiratory311%
Autoimmune / Immune-mediated27%
Injection-site / Local reaction27%
Musculoskeletal14%
Dermatological (non-injection-site)14%
Psychiatric / Neuropsychiatric14%
General / Systemic (non-local)14%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida2
Missouri2
Texas2
California2
North Carolina2
Ohio2
North Dakota2
New Jersey2
Alabama1
Iowa1
Nevada1
Michigan1

Reports by month received

2022-113
2023-011
2023-032
2023-043
2023-054
2023-083
2023-091
2023-113
2023-121
2024-031
2024-041
2024-072
2024-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.